Senior insider sale
Chief Scientific Officer at FULGENT GENETICS, INC. — senior position signals high conviction
$81.8K
4.30K shares
What this filing means
GAO HANLIN plans to sell 4.30K shares of FULGENT GENETICS, INC. valued at approximately $81.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/3/2026ACC: 0001684532-26-000011
Officer· Chief Scientific Officer
Since Feb 2026
4.30K
Shares to sell
$81.8K
Approx. market value
37.79K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted stock vest
Equity compensation for services rendered
2/25/2025
37.79KTotal acquired37.79K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/25/2025 | Restricted stock vest Equity compensation for services rendered | 37.79K | — |
| Total | 37.79K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
939.00
Market value
$18.7K
8/27/2026
—Completed
Units to sell
1.69K
Market value
$30.2K
6/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.67K
Market value
$32.9K
9/2/2026
Total
Units
4.30K
Value
$81.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/27/2026 | 939.00 | $18.7K | — | Completed |
6/2/2026 | 1.69K | $30.2K | — | Completed |
| Planned — Approximate Date | ||||
9/2/2026 | 1.67K | $32.9K | NASDAQ | Planned |
| Total | 4.30K | $81.8K | ||